Genomics firms
Privately held firms in black (listed first),
publicly traded firms in red (listed second)Listed by country of origin, then alphabetically
Updated 10 June 2001
*Patents in DNA Patent Database through Dec 31, 1999 (
www.genomic.org)
Firm Name |
Website |
Public or private? |
Address1 |
Address2 |
City |
State |
PostalCode |
Country |
GeneralPhone |
Fax |
PrimaryContact |
PrimaryContactPhone |
|
Patents* |
Comments |
|
Bresagen |
www.bresagen.com.au |
Privately held |
PO Box 259 |
Rundle Mall |
Adelaide |
5000 |
Australia |
61-8-8234-2660 |
61-8-8234-6268 |
John Smeaton, Managing Director |
Jsmeaton@bresagen.com |
0 |
||||
Exgenix |
www.exgenix.com.au |
Privately held |
576 Swan Street |
Richmond |
Victoria |
3121 |
Australia |
61-3-9208-4444 |
0 |
|||||||
Proteome Systems Ltd |
www.proteomesystems.com |
Privately held |
Locked Bag 2073 |
North Ryde, 1670 |
NSW |
2113 |
Australia |
61-2-9889-1830 |
61-2-9889-1805 |
Keith L. Williams, CEO |
Keith.Williams@ProteomeSystems.com |
0 |
||||
Advanced Array Technology SA |
www.AAT-Array.com |
Privately held |
rue de Bruxelles 61 |
B-5000 |
Namur |
Belgium |
32-81-724151 |
32-81-724135 |
Jose Remacle, Director of Biochemistry and Cellular Biology |
0 |
aat@fundp.ac.be | |||||
Devgen NV |
www.devgen.com |
Privately held |
Technologiepark 9 |
9052 Zwijnaarde |
Belgium |
32-9-264-5402 |
32-9-264-5418 |
Theirry Bogaert, CEO and CSO |
0 |
|||||||
Galileo Genomics Inc. |
www.galileogenomics.com |
Privately held |
6700 avenue du Parc |
Suite 200 |
Montreal |
Quebec |
H2V 4H9 |
Canada |
514-270-3991 ext 224 |
514-270-4991 |
Philippe Douville, VP and CBO |
Pdouville@galileogenomics.com |
0 |
|||
Genechem |
www.genechem.com |
Privately held |
1001, de Maisonneuve O. |
Suite 920 |
Montreal |
Quebec |
H3A 3C8 |
Canada |
514-849-7696 |
Louis Lacasse, President |
0 |
|||||
GeneFocus |
www.genefocus.com |
Privately held |
560 Parkside Drive |
Waterloo |
ON |
N2L 5Z4 |
Canada |
519-886-9013 |
519-886-8442 |
A. E. (Ted) Dixon, President |
519-886-9013 |
Aedixon@confocal.com |
0 |
Subsidiary of Biomedical Photometrics |
||
Inphogene BioCom Inc. |
www.inphogene.com |
Privately held |
309 - 4475 Wayburne Drive |
Burnaby |
BC |
V5G 3L1 |
Canada |
604.453.5900 |
604.453.5910 |
Chris Carthy, President |
0 |
|||||
Integrative Proteomics Inc. |
www.integrativeproteomics.com |
Privately held |
100 University Avenue |
Tenth Floor (South Tower) |
Toronto |
ON |
M5J 1V6 |
Canada |
416-645-6600 |
416-598-1262 |
John Mendlein, CEO |
Info@integrativeproteomics.com |
0 |
|||
Molecular Mining Corp. |
www.molecularmining.com |
Privately held |
128 Ontario Street |
Hamilton |
ON |
K7L 2Y4 |
Canada |
613-547-9752 |
613-547-6835 |
Evan Steeg, President and CEO |
Info@molecularmining.com |
0 |
||||
RabbitHutch Biotechnology Inc. |
www.rabbithutch.com |
Privately held |
Box 506 |
108 Mile Ranch |
BC |
V0K 2ZO |
Canada |
250-791-1937 |
250-791-1938 |
Info@rabbithutch.com |
0 |
|||||
Xenon Bioresearch Inc. |
www.xenonbioresearch.com |
Privately held |
NRC Innovation Centre |
3250 East Mall |
Vancouver |
BC |
V6T 1W5 |
Canada |
604-822-3995 |
604-822-4366 |
Frank Holler, President and CEO |
(0) |
||||
Bios Chile IGSA |
www.bioschile.cl |
Privately held |
Avenida Marathon |
1943 |
Santiago |
Chile |
52-2-2381878 |
56-2-2394250 |
Pablo Valenzuela, CEO |
Ventas@bioschile.cl |
0 |
|||||
Inoxell AS |
www.pharmexa.com for parent company. No specific Inoxell site as of 4 June 2001 (see 30 May press statement) |
Privately held |
6, Kogle Alle |
DK-2970 |
Horsholm |
Denmark |
45 45 16 25 25 |
45 45 16 25 00 |
Peter Kristensen, CEO |
0 |
Spun out of Pharmexa A/S 30 May 2001. Pharmexa formerly M&E Biotech. Website notes 4 patents issued (2 WO, 1 AU, 1 EP) and 7 pending patents (2 US, 2 WO, 1 KR, 1 CA, 1 JP). |
|||||
ExonHunt Therapeutics SA |
www.exonhunt.com |
Privately held |
65 Boulevard Massena |
F-75013 |
Paris |
France |
33-1-53-94-77-00 |
33-1-53-94-77-07 |
Bruno Tocque, CEO |
0 |
||||||
Genfit SA |
www.genfit.com |
Privately held |
Parc Eurasante |
310, avenue Eugene Avinee |
59120 Loos |
France |
33-03-28-55-90-60 |
33-03-28-55-90-61 |
Jean-Charles Furchart, Chairman |
0 |
||||||
GenOdyssee SA |
www.genodyssee.com |
Privately held |
Parc d’Affaires Technopolis |
3, avenue du Canada Bat Alpha, PB 810 |
Courtaboef |
France |
Les Ulis 91974 |
France |
33-1-69-29-80-55 |
33-1-69-29-80-79 |
Jean-Louis Escary, President and CSO; Didier Lanson, CEO |
Escary@genodyssee.com |
0 |
SNP and other genomics; founded with ANVAR funds |
||
Genome Express |
www.genomex.com |
Privately held |
35 Chemin du Vieux Chêne |
Meylan |
38941 |
France |
33 (0)4 76 04 16 42 |
33 (0)4 76 04 16 49 |
Francois Dohet, Marketing and Sales Manager |
Dohet@genomex.com |
0 |
For info in US: 1610 NE Eastgate Blvd Suite 880 Pullman, WA 99163 USA 509-332-8080 |
||||
GenOway |
www.genoway.com |
Privately held |
46 Allee d’Italie |
69007 |
Lyon |
France |
33-146-02-5800 |
33-146-02-2511 |
Alexander Fraichard, CEO |
0 |
||||||
Molecular Engines Laboratories |
www.molecular-engines.com |
Privately Held |
10, rue Mercoeur |
Paris |
75011 |
France |
33-1-55-25-60-63 |
33-1-55-25-60-73 |
Claude Hennion, President and CEO |
Chennion@molecular-engines.com |
0 |
Started firm summer 2000 |
||||
ValiGen SA. |
www.valigen.net |
Privately held |
Tour Neptune |
92086 |
Paris-La-Defense |
France |
33 1 47 67 66 00 |
33 1 49 06 07 15 |
Jean-Louis Pourny, CEO |
0 |
||||||
Atugen AG |
www.atugen.com |
Privately held |
Robert-Rossle-Strasse 10 |
13125 |
Berlin |
Germany USA |
49-30-9489-2700 |
49-30-9489-2701 |
Rudi Neirinckx, CEO, President and chairman |
0 |
||||||
Biomax Informatics AG |
www.biomax.de |
Privately held |
Lochhamer Straße 11 |
Martinsried |
82152 |
Germany |
49-89-89-55-74-0 |
49 89 89-55-74-25 |
Klaus Heumann, CEO |
Info@biomax.de |
0 |
|||||
DeveloGen AG |
www.develogen.com |
Privately held |
Rudolf-Wisselstrasse 28 |
Gottingen |
D-37079 |
Germany |
49-551-505-58512 |
49-551-505-58586 |
Herbert Stadler, CEO |
Stuart@develogen.com is COO, Edward Stuart |
0 |
Merger of Develogen and HepaVax Oct 2000 |
||||
Epigenomics GmbH |
www.epigenomics.com |
Privately held |
Kastanienallee 24 |
D-10435 |
Berlin |
Germany |
49-30-24-34-5-0 |
49-30-24-34-5-555 |
Alexander Olek, President and CEO |
49-30-24345-0 |
Olek@epigenomics.com or danek@epigenomics.com |
0 |
||||
FeBiT GmbH (Perrarius Biotechnology) |
www.febit.com |
Privately held |
Käfertalerstrasse 190 |
Mannheim |
D-68167 |
Germany |
49-621-3804-201 |
49-621-3804-400 |
Peer F. Staehler, CSO |
0 |
||||||
Genomatix |
www.genomatix.de |
Privately held |
Karlstrasse 55 |
München |
Bavaria |
D-80333 |
Germany |
49-89-54 90 83-90 |
49-89-54 90 83-99 |
Thomas Werner, CEO |
49-89-54 90 83-92 |
Werner@gsf.de |
0 |
|||
GenProfile AG |
www.genprofile.com |
Privately held |
Robert-Rossle-Straus |
D-13125 |
Berlin-Buch |
Germany |
49-30-9489-2150 |
49-30-9489-2151 |
Margret Hoehe (Max Delbruck Center) |
0 |
||||||
GPC AG (Genome Pharmaceuticals) |
www.gpc-ag.com |
Privately held |
Fraunhoferstrasse 20 |
D-82152 |
Martinsreid-Munich |
Germany |
49-0-89-85-65-26-00 |
49-0-89-85-65-26-10 |
Bernd Seizinger, CEO |
8 |
0 for GPC but 8 for Mitotix, acquired in 2000 |
|||||
Kelman GmbH |
www.kelman.de |
Privately held |
Innovationspark Wuhlheide, Haus 40 |
Koepenicker Strasse 325 |
Berlin |
D-12555 |
Germany |
49-30-6576-3600 |
49-30-6576-3601 |
Stephan Heymann, CTO |
Info@kelman.de or genenetwork@kelman.de |
0 |
||||
MediGene AG |
www.medigene.de |
Privately held |
Lochhamer Str. 11 |
D-82152 |
Planegg-Martinsreid |
Germany |
49-89-89-56-32-0 |
49-89-89-56-32-20 |
Peter Heinrich, CEO |
0 |
||||||
MediGenomix GmbH |
www.medigenomix.de |
Privately held |
Lochhamer Str.29 |
D-82152 |
Planegg/Martinsreid |
Germany |
49-0-89-89-98-92-12 |
49-0-89-89-98-92-90 |
Hanns-Georg Klein |
0 |
||||||
Morphochem AG |
www.morphochem.com |
Privately held |
Gmunder str. 37-37a |
81370 |
Muenchen |
Germany |
49-0-89-78005-0 |
49-0-89-78005-555 |
Lutz Weber, CEO |
Info@morphochem.com |
0 |
|||||
MWG Biotech AG |
www.mwg.biotech.com |
Privately held |
Anzingerstrasse 7a |
Ebersberg |
NC |
D-85560 |
Germany |
49-0-8092-82890 |
49-0-8092-21084 |
Wolfgang Heinberg, Executive for R&D |
0 |
Joint US-German firm (survey sent to German address) |
||||
Iceland Genomics Corp. |
www.uvs.is and www.icelandgenomics.com although this second site not operating 5 Apr 01 |
Privately held |
Urour Veroandi Skuld Lynghalsi 10 |
Reykjavik |
10 |
Iceland |
354-525-3600 |
354-525-3608 |
Berhard O. Palsson, CEO |
Uvs@uvs.is |
0 |
|||||
EiRx Therapeutics Ltd. |
www.eirxtherapeutics.com |
Privately held |
2800 Airport Business Park |
Kinsale Road |
Cork |
Ireland |
353-021-4320847 |
353-021-4320848 |
Peter Daly, CEO |
Pdaly@eirxtherapeutics.com |
0 |
|||||
HiberGen |
www.hibergen.com |
Privately held |
IDA Business Park |
Bray |
County Wicklow |
Ireland |
353-1-276-9870 |
353-1-276-9888 |
Maurice N. Treacy, CEO |
353-1-808-2438 |
Mtreacy@hibergen.com |
0 |
||||
idGENE Pharmaceuticals Ltd. |
www.idgene.com |
Privately held |
Beit Ofer, 5 Haftzrfi Street |
PO Box 34478 |
Jerusalem |
91344 |
Israel |
972-2-659-5600 |
972-2-659-5601 |
Ariel Darvasi, President and CEO |
Contact@idgene.com |
0 |
||||
Proteologics Inc. |
www.proteologics.com Website not operating 4/5/01 |
Privately held |
5 Oppenheimer Street |
Weizmann Science Park |
Rehovot |
76701 |
Israel |
972-8-947-5666 |
972-8-947-5999 |
Oded Lieberman, President and CEO |
Oded@proteologics.com or olieberman@compuserve.com |
0 |
||||
Dragon Genomics |
www.takara.co.jp |
Privately held |
Takara Shuzo Co., Ltd. |
Biomedical Group |
Seta 3-4-1, Otsu |
Shiga |
520-2193 |
Japan |
81-77-543-7247 |
81-77-543-9254 |
Makoto Moriguchi, President and CEO |
Bio-sm@takara.co.jp |
0 |
Parent company Takara Shuzo has 41 DPP patents |
||
HuBit Genomix |
www.hubitgenomix.com/eng |
Privately held |
Joware Hanzoumon Building 2F |
2-19 Hayabusa-cho, Chiyoda-ku |
Tokyo |
102-0092 |
Japan |
81-3-5212-3360 |
81-3-52123384 |
Hiromichi Kimura, CEO |
0 |
Initially Medical Genome Systems (founded April 2000) |
||||
Medibic |
www.medibic.com |
Privately held |
Japan |
81-3-3280-3987 |
81-3-3280-2255 |
Yasuhiro Hashimoto, CEO |
Info@medibic.com |
0 |
||||||||
SuperBioChips Laboratories Inc. |
www.tissue-array.com |
Privately held |
824-11 Yuksam-dong |
Rm 1403-2 |
Seoul |
135-934 |
Korea |
82-2-3676-8270 |
82-2-3676-8269 |
0 |
||||||
UmanGenomics AB |
www.umangenomics.com |
Privately held |
Umestan |
SE-903 |
Umea |
47 |
Sweden |
46-90-71-80-90 |
46-90-71-80-95 |
Sune Rosell, President |
Info@umangenomics.com |
0 |
||||
Gene Data AG |
www.genedata.com |
Privately held |
Maulbeerstr. 46 |
Basel |
CH-4058 |
Switzerland |
41 61 697 6099 |
41 61 697 7244 |
Othmar Pfannes, CEO |
0 |
||||||
Geneva Bioinformatics |
www.genebio.com |
Privately held |
25 avenue de Champel |
1206 |
Geneva |
Switzerland |
41 22 702.99.00 |
41 22 702.99.99 |
Jenny Fichmann, COO |
0 |
||||||
Galapagos Genomics BV |
www.galapagosgenomics.com |
Privately held |
BioScience Park Leiden |
Zernikedreef 6 |
2333 CL |
Leiden |
The Netherlands |
31-71-524-87-03 |
31-71-524-87-04 |
Onno van de Stolpe, Director |
0 |
Joint Belgian-Dutch firm (survey sent to Belgian address) |
||||
Glaucus Proteomics BV |
www.glaucusprot.nl |
Privately held |
Regulierenring 16 |
Bunnik |
Utrecht |
3981 LB |
The Netherlands |
31-30-243-3834 |
31-30-243-5764 |
Ian Humphery-Smith, COO |
ihs@glacusprot.nl |
0 |
||||
Gendaq |
www.gendaq.com |
Privately held |
1-3 Burtonhole Lane |
London |
NW7 1AD |
UK |
44-20-8982-6738 |
44-20-8982-6748 |
Timothy Brears, CEO |
Pr@gendaq.com |
0 |
|||||
Inpharmatica Ltd. |
Www.inpharmatica.com |
Privately held |
60 Charlotte Street |
London |
W1P 2AX |
UK |
44-0-207-631-4644 |
44-0-207-631-4844 |
Ken Powell, CEO |
K.powell@inpharmatica.com |
0 |
|||||
Microscience Ltd. |
www.microscience.com |
Privately held |
Commonwealth Building |
ICSM Hammersmith Campus |
Du Cane Road |
London |
W12 0NN |
UK |
44-0-20-8383-3301 |
44-0-20-8383-2071 |
Rod Richards, CEO |
r.richards@microscience.com |
0 |
|||
Oxagen Ltd. |
www.oxagen.co.uk |
Privately held |
91 Milton Park |
Abingdon |
Oxon |
OX14 4RY |
UK |
44-0-1235-443300 |
44-0-1235-443301 |
Christine Soden, CFO |
011-44-1235-443300 |
c.soden@oxagen.co.uk |
0 |
|||
Solexa Ltd. |
www.solexa.co.uk |
Privately held |
Chesterford Research Park |
Little Chesterford, nr. Saffron Walden |
Essex |
CB10 1XL |
UK |
44-1799-532-306 |
44-1799-532-301 |
Nick McCooke, President |
Harold.swerdlow@solexa.co.uk |
0 |
||||
Synomics |
www.synomics.com |
Privately held |
Compass House |
Vision Park, Histon |
Cambridge |
CB4 9AD |
UK |
44-1223-257-788 |
44-1226-257-888 |
Paula Zanella, Chairman |
Pzanella@synomics.com |
0 |
||||
Acadia Pharmaceuticals, Inc. |
www.acadia-pharm.com |
Privately held |
3911 Sorrento Valley Blvd. |
San Diego |
CA |
92121 |
USA |
619-558-2871 |
619-558-2872 |
Mark Brann, President and CSO |
2 |
|||||
Adeptient |
www.adeptient.com |
Privately held |
316 Quinnhill Avenue |
Los Altos |
CA |
94024 |
USA |
650-947-9487 |
Gokhan Percin, President and CEO |
Percin@adeptient.com
Or info@adeptient.com |
0 |
|||||
Alanex (owned by Agouron) |
www.agouron.com |
Privately held |
Corporate Headquarters |
10350 North Torrey Pines Rd |
La Jolla |
CA |
92037-1020 |
USA |
858-455-3200 |
858-455-3287 |
Alex Polinsky, Head of Alanex Research Div. |
0 |
||||
Allelix (NPS Pharmaceuticals, Inc.) |
www.npsp.com |
Privately held |
420 Chipeta Way |
Salt Lake City |
UT |
84108 |
USA |
801-583-4939 |
Hunter Johnson, CEO and President |
22 |
||||||
Alpha Gene Inc |
www.alphagene.com |
Privately held |
260 W. Cummings Park |
Woburn |
MA |
01801 |
USA |
781-933-4446 |
781-933-5424 |
Donald J. McCarren, President and CEO |
Info@alphagene.com |
1 |
||||
Anadys Pharmaceuticals Inc. |
www.anadyspharma.com |
Privately held |
9050 Camino Santa Fe |
San Diego |
CA |
92121 |
USA |
858-530-3603 |
858-527-1540 |
Kleanthis G. Xanthopoulos, President and CEO |
Dnelson@anadyspharma.com |
1 |
Formed from merger of Scriptgen and Askelpios. One patent from Scriptgen. |
|||
AnVil Informatics Inc. |
www.anvilinfo.com |
Privately held |
600 Suffolk Street |
5th Floor North |
Lowell |
MA |
01854-3629 |
USA |
(978) 934-8821 |
(978) 937-1850 |
Howard Berke, CEO |
Info@anvilinformatics.com |
0 |
|||
Aptagen |
www.aptagen.com |
Privately held |
520 Huntmar Park Drive |
Herndon |
VA |
20170 |
USA |
888-Aptagen; 703-793-8000 |
703-793-8037 |
Colin Higbie, President and CEO |
Info@aptagen.com |
0 |
||||
Aptus Genomics Inc. |
www.aptusgenomics.com |
Privately held |
Maryland Technology Development Center |
9700 Great Seneca Highway |
Rockville |
MD |
20850 |
USA |
240-453-8494 |
240-453-9409 |
Kevin Chance, President and CEO |
Info@aptusgenomics.com |
0 |
|||
Arcaris Inc. |
www.vegen.com |
Privately held |
615 Arapeen Drive |
Suite 300 |
Salt Lake City |
UT |
84108 |
USA |
801-303-0300 |
M. Scott Salka, CEO |
2 |
|||||
Athersys Inc. |
www.athersys.com |
Privately held |
3201 Carnegie Avenue |
Cleveland |
OH |
44115-2634 |
USA |
216-431-9900 |
216-361-9495 |
Gil Van Bokkelen, President and CEO |
0 |
IPO registered and withdrawn, Spring 2001 |
||||
Aviva Biosciences Corp. |
www.avivabio.com |
Privately held |
11568-9 Sorrento Valley Road |
San Diego |
CA |
92121 |
USA |
858-259-8288 |
858-259-8685 |
Julian Yuan, President and CEO |
Info@avivabio.com |
0 |
||||
Beyond Genomics Inc. |
www.beyondgenomics.com |
Privately held |
150 Cambridge Park Drive |
10th Floor |
Cambridge |
MA |
02140 |
USA |
617-218-1694 |
617-497-2244 |
N. Stephen Ober, President |
Steveo@beyondgenomics.com |
0 |
|||
BioArray Solutions LLC |
www.bioarrays.com |
Privately held |
120 Centennial Ave |
Piscataway |
NJ |
08854 |
USA |
Michael Seul, Founder |
Mseul@bioarrays.com |
0 |
Website lists 3 PCT patents pending and excl license to one US patent |
|||||
BioDiscovery Inc. |
www.biodiscovery.com |
Privately held |
11150 West Olympic Blvd |
Suite 1170 |
Los Angeles |
CA |
90064 |
USA |
(310) 966-9366 |
(310) 966-9346 |
Soheil Shams, President |
info@biodiscovery.com |
0 |
|||
Biognosis Inc. |
www.biognosis.com |
Privately held |
209 Perry Parkway |
Gaithersburg |
MD |
20877 |
USA |
301-921-6001 |
301-921-6011 |
Andrew Pergen, Vice President, Biognosis US |
Abergen@biognosis.com or info@biognosis.com |
0 |
||||
Bionomix Inc. |
www.bionomix.com |
Privately held |
1376 E. Walnut Street |
Pasadena |
CA |
91106 |
USA |
Derek Debe, CEO |
Damin7@kornet.net |
0 |
Linked to Caltech |
|||||
Biosearch Technologies Inc. |
www.biosearchtech.com |
Privately held |
81 Digital Drive |
Novato |
CA |
94949-5750 |
USA |
415-883-8400 or 1-800-436-6631 |
Ron Cook, President and CEO |
Info@biosearchtech.com |
0 |
|||||
BIOwulf Genomics Inc |
Privately held |
Savannah |
GA |
USA |
Peter Farley, President and CEO |
0 |
Distinct from BeoWulf Genomics, a nonprofit initiative of the Wellcome Trust for micribial pathogen sequencing |
|||||||||
Blue Heron |
www.blueheronbio.com |
Privately held |
22310 20th Avenue SE |
Suite 100 |
Bothell |
WA |
98021 |
USA |
425-368-5000 |
425-368-4050 |
Peter R. Nicholson, President and CEO |
Info@blueheronbio.com |
0 |
|||
Capital Genomix Inc. |
www.capitalgenomix.com |
Privately held |
2 Cessna Court |
Gaithersburg |
MD |
20879 |
USA |
301-948-7755 |
301-948-9442 |
William Hearl, President and CEO |
240-401-7496 |
Captlgnomx@aol.com or bhearl@capitalgenomix.com |
0 |
|||
Cartesian Technologies |
www.cartesiantech.com/microarray_products.htm |
Privately held |
17851 Sky Park Circle |
Suite C |
Irvine |
CA |
92614 |
USA |
949-440-3680 |
949-622-0255 |
Tom Tisone, President |
0 |
||||
Celadon Laboratories Inc. |
www.celadonlabs.com |
Privately held |
387 Technology Drive |
College Park |
MD |
20741-3371 |
USA |
301-405-7591 |
301-314-9592 |
Larry Kessner, President and CEO |
Peterson@celadonlabs.com |
0 |
||||
Cellomics Inc. |
www.cellomics.com |
Privately held |
635 William Pitt Way |
Pittsburgh |
PA |
15238 |
USA |
512-826-3600 |
512-826-3850 |
D. Lansing Taylor, President and CEO |
1 |
IPO registered and withdrawn Spring 2001 |
||||
Cellular Genomics Inc. |
www.cellulargenomics.com |
Privately held |
25 Science Park |
New Haven |
CT |
06511 |
USA |
203-776-0829 |
203-776-0852 |
Louis A. Matis, President and CSO |
0 |
|||||
CeMines Inc. |
www.cemines.com |
Privately held |
3082 Evergreen Parkway |
Suite H |
Evergreen |
CO |
80439 |
USA |
866-236-4637 |
303-679-3160 |
Support@cemines.com |
0 |
||||
Cereon Genomics LLC |
www.cereon.com |
Privately held |
45 Sidney Street |
Cambridge |
MA |
02139 |
USA |
617-551-8000 |
617-551-1990 |
David Fischhoff & Mark Trusheim, co-Presidents |
0 |
Subsidiary of Pharmacia, formed in partnership betw. Monsanto and Millennium; agricultural genomics |
||||
Cetek Corp. |
www.cetek.com |
Privately held |
260 Cedar Hill Street |
Marlborough |
MA |
01752 |
USA |
508-229-8900 |
508-229-3344 |
James L. Waters, President and CEO |
j.little@cetek.com |
0 |
||||
Chimerx Inc. |
www.chimerx.com |
Privately held |
6143 North 60th Street |
Milwaukee |
WI |
53218 |
USA |
414-535-9506 or 800-626-7833 |
414-535-9508 |
Chimerx@chimerx.com |
0 |
Reagent firm |
||||
Clinical MicroSensors Inc. |
www.microsensor.com |
Privately held |
126 West Del Mar Boulevard |
Pasadena |
CA |
91105 |
USA |
(626) 584-5900 |
(626) 584-0909 |
Jon Faiz Kayyem, President and CEO |
cms@microsensor.com |
0 |
Website lists 12 licensed or assigned patents Nov 2000 |
|||
Clontech |
www.clontech.com |
Privately held |
1020 East Meadow Circle |
Palo Alto |
CA |
94303 |
USA |
650-424-8222, 800-662-2566 |
650-424-1352, 800-424-1350 |
Kenneth Fong, CEO |
8 |
|||||
Cogent Neuroscience Inc. |
www.cogentneuro.com |
Privately held |
710 West Main Street |
Suite 100 |
Durham |
NC |
27701 |
USA |
Max Wallace, CEO |
0 |
||||||
CombiMatrix Inc. |
www.combimatrix.com |
Privately held |
34935 SE Douglas Street |
Suite 110 |
Snoqualmie |
WA |
98065 |
USA |
425-396-5940 |
425-396-5949 |
Info@combimatrix.com |
0 |
||||
Corimba Inc. |
www.corimba.com *site not working 3/5/01 |
Privately held |
2161 Shattuck Avenue |
Suite 203 |
Berkeley |
CA |
94704 |
USA |
510-548-4574 |
510-548-4594 |
0 |
|||||
DiaDexus, LLC |
www.diadexus.com |
Privately held (IPO registration filed 11/00) |
3303 Octavius Drive |
Santa Clara |
CA |
95054 |
USA |
408-496-6600 |
408-496-5777 |
Patrick Plewman, CEO |
Ir@diadexus.com |
0 |
IPO registration (intent) filed 11/00; has exclusive licenses to several patents, noted on website |
|||
Digital Gene Technologies Inc. |
www.dgt.com |
Privately held |
11149 Torrey Pines Road |
La Jolla |
CA |
92037 |
USA |
858-552-1400 |
858-552-8625 |
Richard Sutcliffe, President and CEO |
Info@dgt.com |
0 |
||||
Discovery BioSciences |
www.discoverybio.com |
Privately held |
655 NE Northlake Way |
Seattle |
WA |
98105 |
USA |
206-675-9220 |
206-675-1125 |
David T. Kingsbury, CEO and Tim Hunkapiller, President |
Info@discoverybio.com |
0 |
Also in Foster City, CA |
|||
Display Systems Biotech |
www.displaysystems.com |
Privately held |
1260 Liberty Way |
Suite B |
Vista |
CA |
92083 |
USA Denmark |
760-599-0598 45-70-22-22-02 |
760-599-9930 45-70-23-23-04 |
Tgj@displaysystems.com |
0 |
Also Denmark: Vestre Teglgade 8 DK-2450 Copenhagen SV |
|||
DNA Dynamics |
www.dnadynamics.com |
Privately held |
3398 Carmel Mountain Road |
Suite 100 |
San Diego |
CA |
92121 |
USA |
877.362.2633 858-523-5000 |
858-523-5001 |
Tina S. Nova, CEO |
0 |
Est. March 2000 |
|||
DNA Sciences Inc. |
www.dna.com |
Privately held |
6540 Kaiser Drive |
Fremont |
CA |
94555 |
USA |
510-494-4000 |
510-494-4010 |
Hugh Rienhoff, Jr., Chairman and CEO |
Info@kivagen.com |
0 |
Formerly Kiva Genetics www.kivagen.com |
|||
DNAmicroarray.com |
www.dnamicroarray.com |
Privately held |
USA |
0 |
No address or corp info available online |
|||||||||||
DNAPrint Genomics |
www.dnaprint.com |
Privately held |
1748 Independence Blvd. |
Suite D1 |
Sarasota |
FL |
34234 |
USA |
941-351-4543 |
941-351-7388 |
Anthony Frudakis, CEO and CSO |
Dnaprint@gte.net Dangenomics@aol.com |
0 |
Does not have patents assigned to the firm, but the website notes the the President and CEO holds 7 patents that cover 350 genes and 2 products |
||
DoubleTwist Inc. |
www.doubletwist.com |
Privately held |
1999 Harrison Street |
Suite 1100 |
Oakland |
CA |
94612 |
USA |
510-628-0100 |
510-628-0108 |
John Couch, President and CEO |
0 |
Includes Pangea (former name) |
|||
Egea Genomics Inc. |
www.egeabiosciences.com |
Privately held |
4178 Sorrento Valley Boulevard |
Suite F |
San Diego |
CA |
92121 |
USA |
858-554-1805 |
858-554-1806 |
Glen A. Evans, President and CEO |
0 |
||||
EngeneOS |
www.engeneos.com |
Privately held |
150 CambridgePark Drive |
10th floor |
Cambridge |
MA |
02140 |
USA |
617-497-2233 |
617-497-2244 |
Frank Lee, President and CEO |
Mail@engeneos.com |
0 |
|||
Entelos Inc. |
www.entelos.com |
Privately held |
4040 Campbell Ave |
Suite 200 |
Menlo Park |
CA |
94025 |
USA |
650-330-5200 |
650-330-5201 |
James Karis, President and CEO |
Company_info@entelos.com |
0 |
|||
Eos Biotechnology Inc. |
www.eosbiotech.com |
Privately held |
225A Gateway Blvd. |
South San Francisco |
CA |
94080 |
USA |
650-246-2300 |
650-583-3881 |
David Martin, CEO and President |
0 |
|||||
Epicentre Technologies Corp. |
www.epicentre.com |
Privately held |
1402 Emil Street |
Madison |
WI |
53713 |
USA |
608-258-8474 888-284-8474 |
608-258-3088 |
Jerome J. Jendrisak |
4 |
|||||
EraGen Biosciences |
www.eragen.com |
Privately held |
12085 Research Drive |
Alachua |
FL |
32615 |
USA |
904-462-2000 |
James Prudent, CSO |
Info@eragen.com |
0 |
0 Patents in DPD, but website lists 6 patents issued and 3 continuations pending, all to company co-founder Stephen A. Benner, Zurich CH and Gainesville FL as inventor; presumably licensed to EraGen |
||||
Fairfield Enterprises Inc. |
Privately held |
PO Box 1366 |
Los Alamos |
NM |
87544 |
USA |
505-662-3115 |
505-662-3123 |
Eric Fairfield, President |
Fairfiel@trail.com |
0 |
Developing "alternatives to luminescence detection" for arrays, etc. |
||||
First Genetic Trust Inc. |
www.firstgenetic.net |
Privately held |
8770 West Bryn Mawr Avenue |
Suite 1300 |
Chicago |
IL |
60631 |
USA |
773-867-2990 |
773-867-2991 |
Arthur L. Holden, CEO |
(773) 867-2990 |
Aholden@firstgenetic.net |
NA |
Focused on privacy of genetic info as trusted intermediary |
|
Gamera BioScience |
www.gamerabioscience.com |
Privately held |
200 Boston Avenue |
Suite 1850 |
Medford |
MA |
02155 |
USA |
781-306-0837 |
John Campbell, Executive Director |
2 |
|||||
GenBasix Inc. |
www.genbasix.com |
Privately held |
1500 E. Duarte Road |
Duarte |
CA |
91010 |
USA |
626-301-8832 |
626-301-8912 |
William L. Hughes, CEO |
0 |
|||||
Gene Tec |
www.ncbiotech.org/genetec.htm |
Privately held |
205 Winterberry Ridge Drive |
Durham |
NC |
27713 |
USA |
919-493-2022 |
Marilyn Stapleton, President |
mstapleton@ntrnet.net |
6 |
|||||
GeneFormatics Inc |
www.geneformatics.com |
Privately held |
5830 Oberlin Drive |
Suite 200 |
San Diego |
CA |
92121-3754 |
USA |
858-450-3331 |
858-450-1138 |
John Chiplin, President and CEO |
Jacque@geneformatics.com Jacquelyn Fetrow, scientific founder |
0 |
|||
GeneGo LLC |
www.genego.com |
Privately held |
21 Chrismar Road |
Portage |
IN |
46368 |
USA |
219-763-9756 |
925-362-9698 |
Tatiana Nikolskaya, President and CEO |
Tatiana@genego.com |
0 |
||||
GeneMachines Inc. |
www.genemachines.com |
Privately held |
935 Washington Street |
San Carlos |
CA |
94070 |
USA |
650-508-1634 |
650-508-1644 |
Scott Hunicke-Smith, CEO |
0 |
|||||
GeneSeek Inc. |
www.geneseek.com |
Privately held |
4701 Innovation Drive |
Lincoln |
NE |
68521 |
USA |
402-472-5133 |
402-472-4203 |
Abe Oommen, President and CEO |
Aoommen@geneseek.com or help@geneseek.com |
0 |
Genotyping and sequencing; farm animal genotyping and diagnosis |
|||
Genetica Inc. |
www.geneticainc.com |
Privately held |
PO Box 99 |
Cold Spring Harbor |
NY |
11724 |
USA |
516-367-8847 |
516-367-8874 |
David Beach, President |
0 |
(3 Patents for a Genetica of Joinville Le Pont, France, but not same company?) |
||||
GeneticXchange |
www.geneticxchange.com |
Privately held |
713 Santa Cruz Avenue |
Menlo Park |
CA |
94025 |
USA |
650-321-9573 |
650-321-9523 |
Su Yun Chung, Chief computational biologist |
Info@geneticxchange.com |
0 |
Collaboration with Stanford University and PharmacoGenetics Knowledge Base www.pharmgkb.org |
|||
GeneTrace Systems Inc. |
www.genetrace.com |
Privately held |
1401 Harbor Bay Parkway |
Alameda |
CA |
94502 |
USA |
510-748-6000 |
510-748-6001 |
George LaMotte, CEO |
Info@genemachines.com |
1 |
||||
Geneva Proteomics |
www.geneprot.com |
Privately held |
1840 Oak Avenue |
Evanston |
IL |
60202 |
USA |
847-344-2887 |
847-328-8432 |
Cedric Loiret-Bernal, CEO |
Cedric.loiret-bernal@geneprot.com |
0 |
||||
Genicon Sciences Corp. |
www.geniconsciences.com |
Privately held |
11585 Sorrento Valley Road |
San Diego |
CA |
92121 |
USA |
(858) 793-0276 |
(858) 793-6791 |
Patrick J. Mallon, President and CEO |
0 |
|||||
Genome Dynamics Inc. |
Privately held |
18247 Flower Hill Way |
Gaithersburgh |
MD |
20855 |
USA |
20879-5536 |
301-926-0921 |
0 |
|||||||
Genome International Corp. |
www.msn.fullfield.com/~sena |
Privately held |
383 D’Onofrio Drive |
Suite 3 |
Madison |
WI |
53719 |
USA |
608-833-5855 |
Periannen Senapathy, President |
Sena@genome.com |
1 |
||||
Genometrix Inc. |
www.genometrix.com or www.mydna.net |
Privately held |
2700 Research Forest Drive |
Suite B7 |
Woodlands |
TX |
77381 |
USA |
281-465-5000 |
281-465-5002 |
Mitch Eggers, CEO |
(0) |
IPO registerd and withdrawn Spring 2001 |
|||
Genomic Health Inc. |
www.genomichealth.com |
Privately held |
Palo Alto |
CA |
USA |
Randy Scott, CEO |
Info@genomichealth.com |
0 |
||||||||
Genomic Profiling Systems |
Privately held |
840 Memorial Drive |
Cambridge |
MA |
02139 |
USA |
617-547-7070 |
617-547-6060 |
Roanna London |
Ext. 25 |
roanna@genprosys.com |
0 |
||||
Genomics Collaborative |
www.dnarepository.com or www.getdna.com |
Privately held |
99 Erie Street |
Cambridge |
MA |
02139 |
USA |
617-661-2400 877-436-6649 |
Michael Pellini, President |
617.661.2400, ext. 2243 |
Mpellini@genecoop.com |
0 |
Formerly Genomics Cooperative |
|||
GenoPlex Inc. |
www.evolgen.com |
Privately held |
6840 N. Broadway |
Suite 200 |
Denver |
CO |
80021 |
USA |
(303)429-5800 |
(303)429-8608 |
Thomas E. Johnson, VP Functional Genomics |
(303)429-5800 ext. 13 |
Tjohnson@genoplex.com |
0 |
||
Golden Helix Inc. |
www.goldenhelix.com |
Privately held |
716 South 20th Street |
Bozeman |
MT |
59718 |
USA |
406-585-8137 |
406-522-1503 |
Christophe Lambert, Ph.D. |
Info@goldenhelix.com |
0 |
||||
Iconix Pharmaceuticals Inc. |
www.iconixpharm.com |
Privately held |
850 Maude Avenue |
Mountain View |
CA |
94043 |
USA |
650-567-5500 |
650-567-5545 |
Keith Bostian, President and CEO |
0 |
|||||
Incogen (Institute for Computational Genomics) |
www.incogen.com |
Privately held |
110 Liberty Drive |
Suite 104 |
Clemson |
SC |
29631 |
USA |
800-286-6599 |
864-654-0887 |
Maciek Sasinowski, CEO and President |
Info@incogen.com | ||||
InGenuity |
www.ingenuity.com |
Privately held |
2160 Gold Street, 2nd Floor |
PO Box 2199 |
Alviso |
CA |
95002-2199 |
USA |
408-957-7777 |
408-957-7782 |
Jake Leschly, President and CEO |
Info@ingenuity.com |
0 |
|||
InPharmix Inc. |
www.inpharmix.com |
Privately held |
PO Box 406 |
Greenwood |
IN |
46142 |
USA |
317-422-1464 |
James P. Sluka, President |
Jsluka@inpharmix.com |
0 |
|||||
Integrated Genomics |
www.integratedgenomics.com |
Privately held |
2201 W. Campbell Park Drive |
Chicago |
IL |
60612 |
USA |
312-491-0846 |
312-491-0856 |
Robert Haselkorn, President and Chairman |
0 |
|||||
LabBook Inc. |
www.labbook.com |
Privately held |
8260 Greensboro Drive |
Suite 100 |
McLean |
VA |
22102 |
USA |
703-770-2800 |
703-288-5512 |
Shawn Gree, Chairman and CEO |
Info@labbook.com |
0 |
|||
LI-COR, Biotechnology Division |
www.licor.com |
Privately held |
4421 Superior Street |
PO Box 4000 |
Lincoln |
NE |
68504 |
USA |
402-467-0700 800-645-4267 |
402-467-0819 |
4 |
|||||
LifeSpan BioSciences Inc. |
www.lsbio.com |
Privately held |
700 Blanchard Street |
Seattle |
WA |
98121 |
USA |
206-464-1554 |
206-464-1723 |
Joseph Brown, President and CEO |
Gene@lsbio.com |
2 |
||||
Mergen Ltd. |
www.mergen-ltd.com |
Privately held |
14826 Wicks Blvd |
San Leandro |
CA |
94577 |
USA |
877.4MERGEN 877-463-7436 510-352-1988 |
510.352.6483 |
Qianjin Hu, President |
0 |
|||||
MicroGenomics |
www.microgenomics.com |
Privately held |
5935 Darwin Court |
Carlsbad |
CA |
92008 |
USA |
760-603-1286 |
760-603-1264 |
Info@microgenomics.com |
0 |
|||||
Mitokor Inc. |
www.mitokor.com |
Privately held |
11494 Sorrento Valley Road |
San Diego |
CA |
92121 |
USA |
858-793-7800 |
858-793-7805 |
Malter Moos, CEO and chairman |
5 |
|||||
Molecular Reflections |
www.molecularreflections.com |
Privately held |
6330 Nancy Ridge Drive |
Suite 107 |
San Diego |
CA |
92121 |
USA |
858-623-0193 |
858-623-0331 |
Michael I. Nerenberg, President and CTO |
Info@molecularreflections.com |
0 |
|||
Molecular Staging Inc. |
Privately held |
New Haven |
CT |
USA |
||||||||||||
Mosaic Technologies |
www.mostek.com |
Privately held |
1106 Commonwealth Ave. |
Boston |
MA |
02215 |
USA |
617-232-7636 |
617-232-7950 |
Michael Woehler, President and CEO |
2 |
|||||
Mycometrix |
www.mycometrix.com |
Privately held |
213 East Grand Avenue |
South San Francisco |
CA |
94080 |
USA |
650.244.1419 |
650.244.1423 |
Gajus Worthington, President and CEO |
gajus.worthington@mycometrix.com |
0 |
Caltech startup |
|||
Nanogen Inc. |
www.nanogen.com |
Privately held |
10398 Pacific Center Court |
San Diego |
CA |
92121 |
USA |
858-410-4600 |
858-410-4848 |
Howard Birndorf, CEO |
4 |
|||||
NetGenics Inc. |
www.netgenics.com |
Privately held |
1717 E. Ninth Street |
Suite 1600 |
Cleveland |
OH |
44114 |
USA |
216-861-4007 888-861-9007 |
216-861-4777 |
Manuel J. Glynias, President and CEO |
0 |
IPO registered Mar 2000, but put on hold |
|||
NewcoGen (Applied Genomic Technologies) |
www.newcogen.com |
Privately held |
150 Cambridge Park Drive |
Cambridge |
MA |
02140 |
USA |
617-497-2233 |
617-497-2244 |
Noubar Afeyan, CEO |
Noubar.afeyan@newcogen.com |
0 |
Applied Genomic Technologies one company under NewcoGen Group |
|||
Odyssey Pharmaceuticals Inc. |
www.odysseypharma.com |
Privately held |
4550 Norris Canyon road |
Suite 140 |
San Ramon |
CA |
94583 |
USA |
925-242-1941 |
925-242-1936 |
Michael J. Powell, President and CSO; Anthony Carrano, Acting Director of Research |
Mpowell@odysseypharma.com or info@odysseypharma.com |
0 |
|||
OmniScience Pharmaceuticals Inc. |
www.omniscience.com |
Privately held |
4665 S. Ash Avenue |
Suite G-18 |
Tempe |
AZ |
85282-6764 |
USA |
480-456-0145 |
480-456-0408 |
Michael Chaparian, President and CSO |
0 |
||||
Ontogeny Inc. |
www.ontogeny.com |
Privately held |
45 Moulton Street |
Cambridge |
MA |
02138 |
USA |
617-876-0086 |
617-876-0866 |
Doros Platika, President and CEO |
2 |
|||||
OriGene Technologies Inc. |
www.origene.com |
Privately held |
6 Taft Court |
Suite 300 |
Rockville |
MD |
20850 |
USA |
301-340-3188 888-267-4436 |
301-340-9254 |
(would not give out name) |
0 |
||||
Orion Genomics LLC |
www.oriongenomics.com |
Privately held |
4041 Forest Park Blvd. |
Saint Louis |
MO |
63108 |
USA |
314-615-6977 |
314-615-6975 |
Richard Wilson, President and CEO |
0 |
|||||
Pangene Corp. |
www.pangene.com |
Privately held |
5500 Stewart Avenue |
Freemont |
CA |
94538 |
USA |
510-360-9100 |
David Zarling, President and CEO |
Info@pangene.com |
1 |
Website lists 8 US and 5 WO patents |
||||
Paradigm Genetics |
www.paradigmgenetics.com |
Privately held |
104 Alexander Drive, Building 2 |
PO Box 14528 |
Research Triangle Park |
NC |
27709 |
USA |
919-544-5578 |
919-544-8193 |
John Ryals, President and CEO |
0 |
||||
PharmaSeq Inc. |
www.pharmaseq.com |
Privately held |
11 Deer Park Drive |
Suite 204 |
Monmouth |
NJ |
08852 |
USA |
732-355-0100 |
732-355-0102 |
Wlodek Mandecki, President and CEO |
Mandecki@pharmaseq.com |
0 |
|||
Phase-1 Molecular Toxicology Inc. |
www.phase1tox.com |
Privately held |
2904 Rodeo Park Drive East |
Santa Fe |
NM |
87505 |
USA |
505.471.8438 |
505.471.8205 |
Vincent Kazmer, CEO |
Contact@phase1tox.com |
0 |
||||
Phylonix Pharmaceuticals Inc. |
www.phylonix.com |
Privately held |
100 Inman Street |
Suite 300 |
Cambridge |
MA |
02139 |
USA |
617-441-6700 |
617-441-6766 |
George N. Serbedzija |
617-441-6700 ext. 13 |
George@phylonix.com |
0 |
||
Physiome Sciences Inc. |
www.physiome.com |
Privately held |
307 College Road East |
Princeton |
NJ |
08540-6608 |
USA |
609-987-1199 |
609-987-9393 |
Jeremy Levin, CEO |
Info@physiome.com |
0 |
||||
Praelux Inc. |
Www.praelux.com |
Privately held |
17 Princess Road |
Lawrenceville |
NJ |
08648 |
USA |
609-620-0220 |
609-620-0222 |
David Livingston, President and CEO |
0 |
Formerly SeQ, Ltd. |
||||
ProCeryon Biosciences Inc. |
www.proceryon.com |
Privately held |
309 West 82nd Street |
New York |
NY |
10024 |
USA |
212-595-1102 |
212-595-1156 |
Alessandro Monge, President and CEO |
0 |
See also ProCeryon GmbH of Austria; ProCeryon renamed from King’s Beech Biosoftware |
||||
Protein Pathways, Inc. |
www.proteinpathways.com |
Privately held |
Suite 304 |
1145 Gayley Avenue |
Los Angeles |
CA |
90024 |
USA |
310-208-8444 |
310-208-8004 |
Todd Yeates, Interim President; Larry Souza, Chairman and founder |
Jkelly@proteinpathways.com, business development |
0 |
|||
Protogene Laboratories Inc. |
www.protogene.com |
Privately held |
303 Constitution Drive |
Menlo Park |
CA |
94025 |
USA |
650-289-2900 |
650-289-2910 |
Christopher R. Wolf, President and CEO |
1 |
|||||
Psychiatric Genomics Inc. |
www.psygenomics.com website not operating 4/5/01 placeholder site at www.fkhealth.com/psychgenpress2.html |
Privately held |
19 Firstfield Road |
Gaithersburg |
MD |
20878 |
USA |
301-556-1310 |
310-556-1350 |
Michael G. Palfreyman, President and CEO |
Mpalfreyman@psygenomics.com or mpalfreyman@aol.com |
0 |
||||
QIK Technology |
www.qiktechnology.com |
Privately held |
PMB 305 |
423 Brookline Avenue |
Boston |
MA |
02215 |
USA |
617-584-7869 |
Samuel E. Driver, President |
Info@qiktechnology.com |
0 |
||||
Quark Biotech Inc. |
www.quarkbiotech.com |
Privately held |
1059 Serpentine Lane |
Pleasanton |
CA |
94566 |
USA |
800-730-5795 |
914-478-7497 |
Daniel Zurr, President and CEO |
0 |
Israeli company, going public H&Q doing IPO, announced June 2000 |
||||
Radius Biosciences Inc. |
www.ultranet.com/~radius |
Privately held |
Box 22 |
Medfield |
MA |
02052 |
USA |
508-359-8828 |
508-359-2940 |
0 |
||||||
RHeoGene LLC |
www.rheogene.com |
Privately held |
706 Forest Street |
Charlottesville |
VA |
22903 |
USA |
804-220-3333 |
804-975-4301 |
Mohan Philip, CSO |
Info@rheogene.com |
0 |
||||
SciTegic Inc. |
www.scitegic.com |
Privately held |
4540 Kearny Villa Road |
Suite 224 |
San Diego |
CA |
92123-1587 |
USA |
858-573-8410 |
858-573-8412 |
Mathew Hahn, President and CEO |
Support@scitegic.com |
0 |
|||
Selective Genetics |
www.selectivegenetics.com |
Privately held |
11035 Roselle Street |
San Diego |
CA |
92121 |
USA |
858-625-0100 |
619-625-0050 |
Andrew Baird, CSO |
Info@selectivegenetics.com |
0 |
||||
Senomyx Inc. |
www.senomyx.com |
Privately held |
11099 Torrey Pines Drive |
La Jolla |
CA |
92037 |
USA |
(858) 646-8300 |
(858) 404-0752 |
Paul Grayson, CEO |
Jean.lockhart@senomyx.com |
0 |
Licensing agreements with Rockefeller, Harvard, Johns Hopkins, U Calif on olfactory and vomeronasal receptor and related genes; company focus is flavor and fragrance molecules |
|||
Sequitur Inc. |
www.sequiturinc.com |
Privately held |
14 Tech Circle |
Suite 210 |
Natick |
MA |
01760 |
USA |
508-650-1459 |
508-650-1625 |
Tod Woolf, VP for technology development |
508-650-1459 Ext 2 |
Twoof@sequiturinc.com |
0 |
||
SeqWright |
www.seqwright.com |
Privately held |
2472 Bolsover |
Suite 425 |
Houston |
TX |
77005 |
USA |
(713) 528-4363 (800) 720-4363 |
(713) 528-6232 |
Fei Lu, Head of Genotyping Dept |
0 |
||||
Signature BioScience |
sig.cncoffice.com/index.html |
Privately held |
21125 Cabot Boulevard |
Hayward |
CA |
94545 |
USA |
510 576 2334 |
510 576 2434 |
Mark McDade, CEO |
Info@signaturebio.com |
0 |
||||
Silicon Genetics |
www.sigenetics.com |
Privately held |
935 Washington Street |
San Carlos |
CA |
94070 |
USA |
650-591-4459 |
650-591-5574 |
Andrew Conway, CEO |
Info@sigenetics.com |
0 |
||||
Softberry inc. |
www.softberry.com |
Privately held |
108 Corporate Park Drive |
Suite 120 |
White Plains |
NY |
10604 |
USA |
(914) 253-8740 |
(914) 253-9224 |
Softberry@softberry.com |
0 |
||||
Spectral Genomics Inc. |
www.spectralgenomics.com |
Privately held |
8080 North Stadium Drive |
Suite 2200 |
Houston |
TX |
77054 |
USA |
713-797-1000 |
713-797-0203 |
Shishir Shah, Principal Scientist |
Sshah@spectralgenomics.com or info@spectralgenomics.com |
0 |
|||
Spotfire |
www.spotfire.com |
Privately held |
60 Hampshire Street |
Cambridge |
MA |
02139 |
USA |
1-800-245-4211 |
617-621-0381 |
Bill Ladd, Director of Bioinformatics |
617-621-0340 |
Bill.Ladd@spotfire.com |
0 |
|||
Structural Bioinformatics Inc |
www.strubix.com |
Privately held |
10929 Technology Place |
San Diego |
CA |
92127 |
USA |
858-675-2400 |
858-451-3828 |
Edward T. Maggio, President and CEO |
emaggio@strubix.com |
0 |
Subsidiary of SBI Advanced Technologies A/S |
|||
Structural GenomiX |
www.stromix.com |
Privately held |
10505 Roselle Street |
San Diego |
CA |
92121 |
USA |
858-558-4850 |
858-558-4859 |
Tim Harris, CEO and President |
Tim@stromix.com |
0 |
||||
Structure Function Genomics |
www.monmouth.com/~spidersigns/SFG |
Privately held |
125 Springdale Road |
Princeton |
NJ |
08540 |
USA |
609-497-9093 |
Stephen Anderson, CEO |
Anderson@mbcl.rutgers.edu |
0 |
|||||
Sunol Molecular Corp. |
www.sunolmolecular.com |
Privately held |
2810 North Commerce Parkway |
Hollywood |
FL |
33025-3958 |
USA |
954-443-8600 |
954-443-8610 |
Hing Wong, President and CEO |
2 |
|||||
Super Array Inc. |
www.superarray.com |
Privately held |
P.O. Box 34494 |
Bethesda |
MD |
20827-0494 |
USA |
(301) 765-9888 |
(301) 765-9859 |
Li Shen, President |
Info@superarray.com |
0 |
||||
TeleChem International Inc. |
Arrayit.com |
Privately held |
524 E. Weddell Drive |
Suite 3 |
Sunnyvale |
CA |
94089 |
USA |
408-744-1331 |
408-774-1711 |
Rene A. Schena, President |
Arrayit@arrayit.com |
0 |
|||
TurboGenomics Inc. |
www.turbogenomics.com |
Privately held |
One Century Tower |
265 Church Street |
New Haven |
CT |
06510 |
USA |
203-974-0470 ext 231 |
203-776-4074 |
Gregory Gardiner, President and CEO |
Ssherman@turbogenomics.com VP operations |
0 |
|||
US Genomics |
www.usgenomics.com |
Privately held |
6H Gill Street |
Woburn |
MA |
01801 |
USA |
(781) 937-5550 |
781-938-0060 |
Eugene Chan, CEO |
Info@usgenomics.com |
0 |
||||
Viaken Systems Inc. |
www.viaken.com |
Privately held |
16 South Summit Avenue |
Suite 250 |
Gaithersburg |
MD |
20877 |
USA |
301-216-3400 |
301-330-6950 |
Keith Elliston, President and CEO |
Keith.elliston@viaken.com or info@viaken.com |
0 |
|||
Xanthon Inc. |
www.xanthoninc.com |
Privately held |
104 Alexander Drive |
Building 5 |
Research Triangle Park |
NC |
27709-2296 |
USA |
919-572-0707 |
919-547-3723 |
Carole Golden, VP for R&D |
1 |
||||
Xenogen |
www.xenogen.com |
Privately held |
860 Atlantic Avenue |
Alameda |
CA |
94501 |
USA |
510-291-6100 or 888-810-8055 |
510-291-6196 |
David W. Carter, Chair and co-CEO; Pamela A. Contag, President and co-CEO |
Info@xenogen.com |
0 |
IPO registered, but withdrawn April 2000 |
|||
Xeotron Corp. |
www.xeotron.com placeholder site 4/5/01 |
Privately held |
8285 El Rio |
Suite 130 |
Houston |
TX |
77054 |
USA |
713-842-2151 |
713-842-9060 |
X. Chuan Zhou, President |
Xczhou@Xeotron.com |
0 |
|||
Zygogen LLC |
www.zygogen.com |
Privately held |
520 Kell Hall |
24 Peachtree Center Avenue |
Atlanta |
GA |
30303 |
USA |
404-523-7309 |
404-523-5974 |
Nina Sawczuk, CEO |
Info@zygogen.com |
0 |
|||
Zyomyx |
www.zyomyx.com |
Privately held |
3911 Trust Way |
Hayward |
CA |
94545 |
USA |
510-266-7500 |
510-784-2569 |
Yasunori Kaneko, CEO |
Info@zyomyx.com |
0 |
||||
Syrrx Inc. |
www.syrrx.com |
Privately held? |
3115 Merryfield Row |
San Diego |
CA |
92121 |
USA |
858-812-1629 |
Wendell Wierenga, CEO |
Ned@syrrx.com |
0 |
|||||
NuTec Sciences, Life Sciences Division |
www.nutecsciences.com |
Privatelyheld |
1201 West Peachtree Street |
Suite 800 |
Atlanta |
GA |
30309 |
USA |
404-870-3300 |
404-870-3310 |
Anthony J. Shuker, President; Michael H. Keehan, CEO |
0 |
Collab with IBM & Emory: informatics |
|||
Autogen Limited |
www.autogenlimited.com.au |
Publicly traded (ATGO Australian Stock Exchange) |
210 Kings Way |
South Melbourne |
Victoria |
3205 |
Australia |
61 3 9234 1188 |
61 3 9234 1198 |
Greg Collier, Chief Scientific Officer |
03 9234 1188 or 0419 897 501 |
autogen@awi.com.au |
0 |
|||
CRS Robotics Corp. |
www.crsrobotics.com |
Publicly traded on Toronto SE (ROB) |
5344 John Lucas Drive |
Burlington |
Ontario |
L7L 6A6 |
Canada |
(905) 332-2000 800-365-7587 |
(905) 332-1114 |
Ralph Steedman, President and CEO |
0 |
|||||
Genomics One Corporation |
www.genomicsone.com |
Publicly traded on Montreal Eschange (GNX) |
3030 Le Carrefour Blvd. |
Suite 902 |
Laval |
Quebec |
H7T 2P5 |
Canada |
(877)684-3637 |
Dr. Suzanne Lebel, President |
(450)688-4499 |
slebel@genomicsOne.com |
0 |
|||
Inex Pharmaceuticals |
www.inexpharm.com |
Publicly traded on Toronto Exchange (IEX) |
100-8900 Glenlyon Parkway |
Glenlyon Business Park |
Burnaby |
BC |
V5J 5J* |
Canada |
604-419-3200 |
604-419-3201 |
David J. Main, President and CEO |
Info@inexpharm.com |
2 |
|||
SignalGene Inc. |
www.signalgene.com |
Publicly traded (SGI) |
8475 Christophe-Colomb Avenue |
Suite 1000 |
Montreal |
Quebec |
H2M 2N9 |
Canada |
(514)850-2400 |
(514)850-2424 |
Michael Dennis, President, Chairman, and CEO |
Michael.dennis@signalgene.com |
0 |
|||
Visible Genetics |
www.visiblegenetics.com |
Publicly traded (VGIN) |
700 Bay Street |
Suite 1000 |
Toronto |
Ontario |
M5G 1Z6 |
Canada |
416-813-3240 |
416-813-3250 |
Richard Daly, President and CEO |
Info@visgen.com |
17 |
|||
Genset SA |
www.genxy.com |
Publicly traded (GENXY) |
24, rue Royale |
75008 Paris |
France |
+33 1 55 04 59 00 |
+33 1 55 04 59 29 |
Daniel Cohen, Chief Genomics Officer |
Daniel.cohen@genset.fr |
1 |
SurGen agreement with Royal Coll Surg/Ireland; not separately listed |
|||||
GeneScan Europe AG |
www.biochip.com |
Publicly traded on Neuer Market (GEP) |
Engesserstr. 4 b |
79108 |
Freiburg |
Germany |
0761-5038-0 |
0761-5038-111 |
Ulrich Birsner, CEO |
0 |
12 subsidiary companies; no DPD patents for BioChip, GeneScan, or BioRobotics, but refers to a "large patent portfolio at its disposal" and several pending patents on its website |
|||||
LION BioScience AG |
www.lionbioscience.com |
Publicly traded (LEON) |
Im Neuenheimer Feld 517 |
Heidelberg |
D 69120 |
Germany |
49-6221-403-823 |
49-6221-403-835 |
Friedrich von Bohlen, CEO |
0 |
IPO July 10, 2000 |
|||||
MorphoSys GmbH |
www.morphosys.de |
Publicly traded on Neuer exchange (MOR) |
Lena-Christ-Straße 48 |
D- 82152 |
Martinsreid/Munich |
Germany |
49 (0)89 89927 0 |
49 (0)89 89927 222 |
Simon E. Moroney, CEO |
Info@morphosys.de |
1 |
|||||
deCODE Genetics |
www.decode.is |
Publicly traded (DCGN) |
Lynghalsi 1 |
Rekjavik |
IS-100 |
Iceland |
354-577-1900 |
354-577-1901 |
Kari Stefansson, President and CEO |
Kstefans@decode.is |
0 |
IPO July 2000 |
||||
Compugen Ltd. |
www.cgen.com |
Publicly traded (CGEN) |
72 Pinchas Rosen Street |
Tel Aviv |
69512 |
Israel |
972-3-765-8585 |
972-3-765-8555 |
Mor Amitai, CEO |
Info@cgen.com |
0 |
Founded 1993, IPO Aug 2000 |
||||
Keryx Biopharmaceuticals Inc. |
www.keryxbiopharm.com |
Publicly traded (KERX) |
Kiryat Mada 5 |
Har Hotzvim |
Jerusalem |
91326 |
Israel |
972-2-541-2700 |
972-2-541-2701 |
Morris Laster, CEO |
0 |
IPO June 2000 |
||||
Biacore AB |
www.biacore.com |
Publicly traded (BCOR) |
Radsgatan |
SE-754 50 |
Uppsala |
Sweden |
46 18 675700 |
46 18 150110 |
Ulf Jonsson, President |
Develop-bia@biacore.com |
2 |
|||||
Pyrosequencing AB |
www.pyrosequencing.com |
Publicly traded (PYRO A: Stockholm) |
SE-752 |
Uppsala |
28 |
Sweden |
46-18-565-900 |
46-18-516000 |
Erik Wallden, President and CEO |
Info@pyrosequencing.com |
0 |
|||||
Cytomyx |
www.cytomyx.com |
Publicly traded (EPIC-CYX) on AIM |
140 Science Park |
Cambridge |
CB4 0GF |
UK |
44-1223-508191 |
44-1223-508198 |
Info@cytomyx.com |
0 |
Formerly Cambridge BioScience; IPO May 29.2001 |
|||||
Genetix |
www.genetix.co.uk |
Publicly traded (GTX.L) on FTSE |
Queensway |
New Milton |
Hampshire |
BH25 5NN |
UK |
01-425-624-600 |
01-425-624700 |
Mark Reid, CEO |
0 |
Acquired Genpak Ltd. IPO November 2000 |
||||
Oxford GlycoSciences plc |
www.ogs.com |
Publicly traded on London Exchange (OGS) |
2 The Quadrant, Barton Lane |
Abingdon Science Park |
Abingdon |
Oxon |
OX16 3J |
UK |
(44)1235-543200 |
(44)1235-554701 |
Michael Kranda, CEO |
(44)1235-543200 |
michael.kranda@ogs.co.uk |
5 |
(Patents for Oxford gene systems =3, Oxford technologies 1, Oxford biomedica 1; See also ISIS Innovation with 7 patents) |
|
Pharmagene PLC |
www.pharmagene.com |
Publicly traded on London Exchange (PGN) |
Orchard Road |
Royston |
Hertfordshire |
SG8 5HD |
UK |
44 0-1763 211 600 |
44-1-1763-211 630 |
Alastair Riddell, CEO |
Alastair.riddell@pharmagene.com |
0 |
IPO 7/2000 |
|||
Abgenix |
www.abgenix.com |
Publicly traded (ABGX) |
7601 Dumbarton Circle |
Fremont |
CA |
94555 |
USA |
(510)608-6500 |
(510)608-6589 |
R. Scott Greer, Chairman, President and CEO |
4 |
|||||
Aclara Biosciences Inc. |
www.aclara.com |
Publicly traded (ACLA) |
1288 Pear Avenue |
Mountain View |
CA |
94034 |
USA |
650-210-1200 |
Joseph M. Limber, President and CEO |
Jlimber@aclara.com |
0 |
|||||
Affymetrix Inc. |
www.affymetrix.com |
Publicly traded (AFFX) |
3380 Central Expressway |
Santa Clara |
CA |
95051 |
USA |
(408)731-5000 |
(408)481-0422 |
Stephen Fodor, CEO |
25 |
|||||
Applied Biosystems |
www.appliedbiosystems.com |
Publicly traded (ABI) |
850 Lincoln Centre Drive |
Foster City |
CA |
94404 |
USA |
650-638-5800 800-345-5224 |
650-638-5884 |
Michael Hunkapiller, President |
24 |
Includes PerSeptive Biosystems patents (4); name reverted to Applied Biosystems July 2000 (was PE Biosystems 1997-2000) |
||||
Applied Molecular Evolution Inc. |
www.AMEvolution.com |
Publicly traded (AMEV) |
3520 Dunhill Street |
San Diego |
CA |
92121 |
USA |
858-597-4990 |
858-597-4950 |
William D. Huse |
Lblock@amevolution.com |
6 |
Formerly Ixsys; IPO July 2000 (Patents include Ixsys) |
|||
ARIAD Pharmaceuticals Inc. |
www.ariad.com |
Publicly traded (ARIA) |
26 Landsdowne Street |
Cambridge |
MA |
02139 |
USA |
(617)494-0400 |
(617)494-8144 |
Harvey J. Berger, Chairman and CEO |
1 |
|||||
Array BioPharma |
www.arraybiopharma.com |
Publicly traded (ARRY) |
1885 33rd Street |
Boulder |
CO |
80301 |
USA |
303-381-6600 |
303-449-5376 |
Robert E. Conway, CEO |
0 |
IPO Nov 2000 |
||||
Aurora Biosciences Corp. |
www.aurorabio.com |
Publicly traded (ABSC) |
11010 Torreyana Road |
San Diego |
CA |
92121 |
USA |
(619)404-6600 |
(619)404-6714 |
Timothy J. Rink, President, Chairman, and CEO |
5 |
3 for Aurora; 2 for PanVera, acquired in Feb 2001; Intention of Vertex Pharmaceuticals to purchase Aurora in Fall 2001 announced May 2001 |
||||
AVI BioPharma |
www.avibio.com |
Publicly traded (AVII; AVIIW; AVIIZ) |
One SW Columbia Street |
Suite 1105 |
Portland |
OR |
97258 |
USA |
503-227-0554 |
503-227-0751 |
Denis R. Burger, CEO |
Avi@avibio.com |
1 |
Assigned to AntiVirals Inc. (former name) Also licensed 11 patents from Ohio State Univ, 16 from Univ Nebraska |
||
AxyS Pharmaceuticals Inc. |
www.axyspharm.com |
Publicly traded (AXPH) |
180 Kimball Way |
South San Francisco |
CA |
94080 |
USA |
(650)829-1000 |
(650)829-1001 |
John P. Walker, Chairman and CEO |
5 |
(Patents include Sequana) |
||||
Caliper Techologies Corp. |
www.calipertech.com |
Publicly traded (CALP) |
605 Fairchild Drive |
Mountain View |
CA |
94043-2324 |
USA |
650-623-0700 |
650-623-0500 |
Daniel L. Kisner, CEO and President |
Info@calipertech.com |
3 |
1999 annual report states the company owns 52 patents (DPD count to left contains only DNA-based patents). Most Caliper patents are in microfluidics |
|||
Celera Genomics |
www.celera.com |
Publicly traded (CRA) |
45 West Gude Drive |
Rockville |
MD |
20850 |
USA |
(877)CELERA1 |
(240)453-4000 |
J. Craig Venter, CEO |
0 |
(Patents for Perken-Elmer, Applied Biosystems, PerSeptive Biosystems or PE Corp. = 63) |
||||
Cepheid |
www.cepheid.com |
Publicly traded (CPHD) |
1190 Borregas Avenue |
Sunnyvale |
CA |
94089-1302 |
USA |
408-541-4191 |
408-541-4192 |
Thomas Gutshall, CEO |
0 |
|||||
Ciphergen Biosystems |
www.ciphergen.com |
Publicly traded (CIPH) |
6611 Dumbarton Circle |
Freemont |
CA |
94555 |
USA |
510-505-2100 |
510-505-2101 |
William E. Rich, President and CEO |
0 |
IPO Sept 2000 |
||||
Corixa |
www.corixa.com |
Publicly traded (CRXA) |
1124 Columbia Street |
Suite 200 |
Seattle |
WA |
98104-2040 |
USA |
206-754-5711 |
206-754-5715 |
Steven Gillis, Chairman and CEO |
Info@corixa.com |
4 |
|||
CuraGen Corp. |
www.curagen.com |
Publicly traded (CRGN) |
555 Long Wharf Drive |
11th floor |
New Haven |
CT |
06511 |
USA |
(888)GENOMICS |
203-401-3331 |
Jonathan M. Rothberg, CEO |
3 |
||||
Deltagen |
www.deltagen.com |
Publicly traded (DGEN) |
1003 Hamilton Court |
Menlo Park |
CA |
94025 |
USA |
650-752-0200 |
650-752-0202 |
William Matthews, CEO |
650-752-0208 |
Matthews@deltagen.com |
0 |
IPO Aug 2000 |
||
Diversa Corp. |
www.diversa.com |
Publicly traded (DVSA) |
10665 Sorrento Valley Road |
San Diego |
CA |
92121 |
USA |
619-453-7020 |
619-453-7032 |
Terrance Bruggamen, Chairman and CEO |
20 |
|||||
EXACT Sciences Corp |
www.exactsciences.com |
Publicly tranded (EXAS) |
63 Great Road |
Maynard |
MA |
01754 |
USA |
978-897-2800 |
978-897-3481 |
Don M. Hardison, President |
dhardison@exactsciences.com |
7 |
10 patents listed as of February 2000; formerly Exact Laboratories, Inc.; IPO Feb 2001 |
|||
Exelixis Pharmaceuticals Inc. |
www.exelixis.com |
Publicly traded (EXEL) |
260 Littlefiled Ave. |
South San Francisco |
CA |
94080 |
USA |
650-825-2200 |
650-825-2205 |
George Scangos, President and CEO |
0 |
(Website notes 2 patents, but not contained in DPD through Dec ’99) |
||||
Genaera |
www.genaera.com |
Publicly traded (GENR) |
5110 Campus Drive |
Plymouth Meeting |
PA |
19462 |
USA |
(610) 941-4020 |
(610) 941-5399 |
Roy C. Levitt, President and CEO |
Info@genaera.com |
4 |
Former name Magainin (to which name patents are assigned) |
|||
Genaissance Pharmaceuticals Inc. |
www.genaissance.com |
Publicly traded (GNSC) |
5 Science Park |
New Haven |
CT |
06511 |
USA |
203-773-1450 |
203-562-9377 |
Gualberto Ruano, CEO and President |
1 |
|||||
Gene Logic Inc. |
www.genelogic.com |
Publicly traded (GLGC) |
708 Quince Orchard Road |
Gaithersburg |
MD |
20878 |
USA |
(301)987-1700 |
(301)987-1701 |
Mark D. Gessler, President and COO |
3 |
(Patents include Oncormed, purchased 12/98) |
||||
Genetic Vectors Inc. |
www.gvec.com |
Publicly traded on OTC (GVEC) |
5201 NW 77th Avenue |
Suite 100 |
Miami |
FL |
33166 |
USA |
305-716-0000 |
305-716-0001 |
Mead McCabe, Jr., CEO |
305-716-0000 |
Info@gvec.com |
0 |
Acquired DNA Sciences, Inc (of San Diego, different from DNA Sciences, Inc above) 2/2000 |
|
Genome Therapeutics Corp. |
www.cric.com or www.genomecorp.com |
Publicly traded (GENE) |
100 Beaver Street |
Waltham |
MA |
02453-8443 |
USA |
(781)398-2300 |
(781)893-9535 or -8277 |
Robert J. Hennessey, President, Chairman, and CEO; Bernard Seizinger, CSO |
Robert.Hennessey@genomecorp.com |
8 |
Patents include from Collaborative Research Labs |
|||
Genomic Solutions |
www.genomicsolutions.com |
Publicly traded (GNSL) |
4355 Varsity Drive |
Ann Arbor |
MI |
48108 |
USA |
(734)975-4800 or 877-genomic |
(734)975-4808 |
Jeffrey S. Williams, CEO |
Info@genomicsolutions.com |
0 |
||||
Genomica Corporation |
www.genomica.com |
Publicly traded (GNOM) |
4001 Discovery Drive |
Suite 130 |
Boulder |
CO |
80303 |
USA |
(303)402-9800 |
(303)402-9877 |
James Clemens, VP of Development |
Clemens@genomica.com |
0 |
IPO 28 Sept 2000 |
||
Human Genome Sciences Inc. |
www.hgsi.com |
Publicly traded (HGSI) |
9410 Key West Avenue |
Rockville |
MD |
20850 |
USA |
(301)309-8504 |
(301)309-8512 |
William Haseltine, President |
106 |
(128 patents through 6/12/2000) |
||||
Hyseq Inc. |
lyra.genesolutions.com/jsp/indexmain.jsp www.hyseq.com |
Publicly traded (HYSQ) |
670 Almanor Avenue |
Sunnyvale |
CA |
94086 |
USA |
(408)524-8100 |
(408)524-8141 |
Lewis S. Gruber, President and CEO |
4 |
|||||
Illumina Inc. |
www.illumina.com |
Publicly traded (ILMN) |
9390 Towne Centre Drive |
Suite 200 |
San Diego |
CA |
92121 |
USA |
(858) 587-4290 |
(858) 587-4297 |
Jay Flatley, President and CEO |
(858)587-4233 |
jflatley@illumina.com |
0 |
||
Incyte Genomics Inc. |
www.incyte.com |
Publicly traded (INCY) |
3174 Porter Drive |
Palo Alto |
CA |
94304 |
USA |
(650)855-0555 |
(650)855-0572 |
Randal W. Scott, President and CSO |
Randy@incyte.com |
276 |
(474 patents through 6/12/2000) |
|||
InforMax Inc. |
www.informaxinc.com |
Publicly traded (INMX) |
6010 Executive Boulevard |
10th floor |
North Bethesda |
MD |
20852 |
USA |
240-223-0100 301-984-2206 |
240-223-3201 |
Alexander Titomirov |
0 |
IPO 28 Sept 2000 |
|||
Invitrogen Inc. |
www.invitrogen.com |
Publicly traded (IVGN) |
1600 Faraday Avenue |
Carlsbad |
CA |
92008 |
USA |
800-955-6288 |
760-603-7201 |
Lyle C. Turner, Chairman and CEO |
2 |
Purchasing Life Technologies; deal to close by end of 2000. |
||||
Large Scale Biology (and Proteomics) |
www.lsbc.com |
Publicly traded (LSBC) |
3333 Vaca Valley Pkwy |
Suite 1000 |
Vacaville |
CA |
95688 |
USA |
707-446-5501 |
707-446-3917 |
Robert L. Erwin, President and CEO |
17 |
BioSource Technologies purchased and changed names to Large Scale Biology 1999 (count includes both Cos.); IPO Aug 2000 |
|||
Lexicon Genetics Incorporated |
www.lexicon-genetics.com see also www.lexgen.com |
Publicly traded (LEXG) |
4000 Research Forest Drive |
The Woodlands |
TX |
77381-4287 |
USA |
(281)364-0100 |
(281)364-0155 |
Arthur Sands, President and CEO |
(281)364-0100 |
jgregory@lexgen.com |
0 |
Knockout mouse initiative through Merck Genome Research Institute |
||
Lynx Therapeutics Inc. |
www.lynxgen.com |
Publicly traded (LYNX) |
25861 Industrial Blvd. |
Hayward |
CA |
94545 |
USA |
(510)670-9300 |
(510)670-9302 |
Norman J. W. Russell, President and CEO |
27 |
|||||
Maxygen Inc. |
www.maxygen.com |
Publicly traded (MAXY) |
515 Galveston Drive |
Redwood City |
CA |
94063 |
USA |
650-298-5300 |
650-364-2715 |
William P. C. Stemmer, Vice President for Research |
1 |
|||||
Millennium Pharmaceuticals Inc. |
www.mlnm.com |
Publicly traded (MLNM) |
75 Sidney Street |
Cambridge |
MA |
02139 |
USA |
(617)679-7000 |
(617)374-9379 |
Steven H. Holtzman, Chief Business Officer |
617-679-7219 |
holtzman@mpi.com |
49 |
(Includes 3 for "Millenium" misspelled) |
||
Molecular Devices Corp. |
www.moleculardevices.com |
Publicly traded NASDAQ: (MDCC) |
1311 Orleans Drive |
Sunnyvale |
CA |
94089 |
USA |
800-635-5577 |
Joseph D. Keegan, President and CEO |
0 |
Merger of LJL BioSystems July 2000 |
|||||
Myriad Genetics Inc. |
www.myriad.com |
Publicly traded (MYGN) |
320 Wakara Way |
Salt Lake City |
UT |
84108 |
USA |
(801)584-3600 |
(801)584-3640 |
Mark Skolnick, CSO |
16 |
|||||
Onyx Pharmaceuticals Inc. |
www.onyx-pharm.com |
Publicly traded (ONXX) |
3031 Research Drive |
Richmond |
CA |
94806 |
USA |
(510)222-9700 |
(510)222-9758 |
Allan Balmain, VP for Research |
13 |
|||||
Orchid BioSciences Inc. |
www.orchidbio.com
or www.orchid.com |
Publicly traded (ORCH) |
303 College Road East |
Princeton |
NJ |
08540 |
USA |
609-750-2200 |
609-750-2250 |
Dale Pfost, President an CEO |
2 |
Started as Orchid Biocomputers Inc. |
||||
OSI Pharmaceuticals |
www.osip.com |
Publicly traded (OSIP) |
777 Old Saw Mill River Road |
Tarrytown |
NY |
10591-6705 |
USA |
914-467-6200 (Corp HQ in Uniondale 516-222-0023) |
516-222-0114 |
Benjamin Benton, Head of Functional Genomics |
914-345-6200, ext 314 |
Bbenton@osip.com |
0 |
|||
Packard Bioscience |
www.packardbioscience.com |
Publicly traded (PBSC) |
800 Research Parkway |
Meriden |
CT |
06450 |
USA |
203-238-2351 800-243-4422 201-329-8660 |
Emery G. Olcott, CEO |
Mpassavant@packardbioscience.com |
1 |
|||||
Pathogenesis Corp.. |
www.pathogenesis.com |
Publicly traded (PGNS) |
201 Elliott Avenue West |
Seattle |
WA |
98119 |
USA |
206-467-8100 |
206-270-313 |
Wilbur H. Gantz, Chairman and CEO |
3 |
|||||
Pharsight Corp. |
www.pharsight.com |
Publicly traded; subsidiary NASDAQ: PHST |
11230 Sorrento Valley Road |
Suite 140 |
San Diego |
CA |
02121 |
USA |
858-625-1343 650-314-3889 Mtn View |
858-597-1353 |
Janice H. Kurth, VP Genomics |
Jkurth@pharsight.com |
0 |
Pharsight mainly a clinical research management firm; genomics branch started 2000 |
||
Protein Design Labs |
www.pdl.com |
Publicly traded (PDLI) |
34801 Campus Drive |
Fremont |
CA |
94555-3606 |
USA |
(650)903-3700 |
(650)903-3730 |
Laurence Jay Korn, Chairman and CEO |
7 |
|||||
Rigel Inc. |
www.rigel.com |
Publicly traded (RIGL) |
240 E. Grand Avenue |
South San Francisco |
CA |
94080 |
USA |
650-624-1100 |
650-624-1101 |
James Gower, President and CEO |
0 |
IPO 11/28/00 |
||||
Seattle Genetics Inc. |
www.seattlegenetics.com |
Publicly traded (SGEN) |
22215 26th Avenue SE |
Suite 3000 |
Bothell |
WA |
98021 |
USA |
425-489-4990 |
425-489-4798 |
H. Perry Fell, CEO |
0 |
IPO Mar 2001; has licenses to patents from CEO and CSO |
|||
Sequenom Inc. |
www.sequenom.com |
Publicly traded (SQNM) |
11555 Sorrento Valley Road |
San Diego |
CA |
92121-1331 |
USA |
858-350-0345 |
858-350-0344 |
Hubert Koster, President and CEO |
8 |
6 Sequenom + 2 Gemini Genomics; announced acquisition of Gemini May 2001. Total of 11 issued gene patents and 89 pending; 59 issued or allowed technology patents with 96 pending between the two companies as of May 2001. |
||||
Targeted Genetics Corp. |
www.targen.com |
Publicly traded (TGEN) |
1100 Olive Way |
Suite 100 |
Seattle |
WA |
98101 |
USA |
206-623-7612 |
206-623-0288 |
H. Stewart Parker, President and CEO |
3 |
||||
Third Wave Technologies Inc. |
www.twt.com |
Publicly traded (TWTI) |
502 South Rosa Road |
Madison |
WI |
53719 |
USA |
888-898-2357 608-273-8933 |
608-273-8618 |
Lance Fors, CEO |
12 |
Plan for acquisition by PE Biosystems announced 1/24/2000. Merger canceled 5/2000. IPO announced, delayed; occurred Feb 2001. |
||||
Transgenomic Inc. |
www.transgenomic.com |
Publicly traded (TBIO) |
5600 South 42nd Street |
Omaha |
NE |
68107 |
USA |
(402) 733-2829 (800) 369-2822 |
402-733-1932 |
Collin D'Silva, CEO |
Info@transgenomic.com |
0 |
Services Co., IPO 7/2000 |
|||
Tripos |
www.tripos.com |
Publicly traded (TRPS) |
1699 South Hanley Road |
Saint Louis |
MO |
63144-2913 |
USA |
314-647-1099 or 800-323-2960 |
314-6479241 |
John P. McAlister III, President and CEO |
Info@tripos.com |
0 |
||||
Valentis Inc. |
www.valentis.com |
Publicly traded (VLTS) |
863A Mitten Road |
Burlingame |
CA |
94010 |
USA |
650.697.1900 |
650.652.1990 |
Banjamin F. McGraw, President and CEO |
Ben@valentis.com |
info@Valentis.com |
4 |
Formed from merger of PolyMASC, GeneMedicine, and Megabios; website listed 58 Issued US patents 2/15/01 |
||
Variagenics Inc. |
www.variagenics.com |
Publicly traded (VGNX) |
60 Hampshire Street |
Cambridge |
MA |
02139-1562 |
USA |
617-588-5300 |
617-588-5399 |
Taylor Crouch, President and CEO |
0 |
Pharmacogenetics, IPO 7/2000 |
||||
Vysis Inc. |
www.vysis.com |
Publicly traded (VYSI) |
3100 Woodcreek Drive |
Downers Grove |
IL |
60515-5400 |
USA |
(800)553-7042 |
(630)271-7138 |
John L. Bishop, President and CEO |
4 |
|||||
Xenometrix |
www.xeno.com |
Publicly traded OTCBB:XENO.OB |
2425 North 55th Street |
Boulder |
CO |
80301-5700 |
USA |
303-447-1773 |
303-447-1758 |
Pauline Gee, President and CEO |
Pgee@xeno.com |
1 |
Acquired by Discovery Partners Feb 2001 (NASDAQ: DPII); Quarterly 10QSB SEC of 2/14/01 also notes EPO patent and "similar patents" but does not further specify them. |